Work

Combination Therapy Using Ruxolitinib and Oncolytic HSV Renders Resistant MPNSTs Susceptible to Virotherapy

Year: 2018

Type: article

Source: Cancer Immunology Research

DOI: 10.1158/2326-6066.cir-18-0014

Authors: Mohammed G. Ghonime, Kevin A. Cassady

Institutions: Nationwide Children's Hospital, The Ohio State University

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Defense, Alex's Lemonade Stand Foundation for Childhood Cancer, Hyundai Motor Group, National Cancer Institute, Hyundai Hope On Wheels

Award: Cancer Center Support Grant

OpenAlex ID: W2897351024

FWCI: 2.299

Cites: 54

Cited by: 46

Related to: 10